Pulmonary Complications of Allografts (ALLOPULM)

Assistance Publique - Hôpitaux de Paris

Status: Completed

Conditions: Pulmonary Complications

Study type: Observational

Funder types: Other

Identifiers

NCT01219972

CRC 04118

Details and patient eligibility

About

This is a prognostic study of the late lung complications arising at the patient's having received an allograft of hematopoetic stem cells.

Full description

• Objectives To estimate the incidence of late (at least occurring 100 days after transplantation) pulmonary complications following allogeneic blood stem cells transplantation
• Study Design Prospective Cohort Study All follow-up data were actualiized in September, 2016.
• Sample Size 200 transplanted patients
• Main Endpoint Non infectious pulmonary complications within the first 3 years

Enrollment: 245 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Allogeneic Blood stem cell transplantation
• Alive at day 100 post-transplant

Exclusion criteria

• Non informed consent

Trial design

245 participants in 1 patient group

Allografted patients

Description:

* All consecutive patients who underwent an allogeneic blood stem cells transplantation performed at saint Louis hospital during the study recruitment period * if alive at 100 days post-transplant * and who gave informed consent